The science
Powered by Digexin™*
A proprietary blend of ashwagandha and tender okra extracts, developed by NXT USA, Inc. and tested in double-blind, randomised, placebo-controlled human trials.
Tender okra
Hibiscus esculentus
Extract of the young, tender pod.
Ashwagandha root
Withania somnifera
Extract of the root.
Digexin™ is backed by multiple clinical trials.
Results relate to Digexin™, the active ingredient, not to ILURA Digest + Balance as a finished product. Digexin clinical study, NXT USA, September 2025. Double-blind, randomised, placebo-controlled. Individual results vary. *Digexin™ is a trademark of NXT USA, Inc.
Trial · Gold standard
Double-blind, randomised, placebo-controlled.
The most rigorous way to test an ingredient. Neither participants nor researchers knew who received Digexin™ and who received placebo, so the results reflect the ingredient, not expectation.
- Design
- Double-blind, randomised
- Compared against
- Placebo
Results relate to Digexin™, the active ingredient, not to ILURA Digest + Balance as a finished product. CLS/GH/CL18100F4/24 Digexin clinical study, NXT USA, September 2025. Individual results vary.
Digexin™ trial · Adults on a GLP-1 program
Studied in people on a GLP-1 program.
Three weeks of Digexin™ in participants already experiencing gastrointestinal side effects while on treatment.
- Improved digestive comfort
- Reduced constipation and reflux
- More regular bowel movements
- Design
- Open label
- Participants
- Adults on a GLP-1 program
- Duration
- Three weeks
- Adverse events
- None recorded
Trial · Transit time
The blue poo test.
A simple, objective measure of how quickly food moves through the gut. Participants eat a meal coloured with a harmless blue dye, then record when blue first appears in their stool.
- 01 Eat a blue-dyed meal
- 02 Note the time
- 03 Record the first blue stool
Transit time measured by blue dye test, before and after supplementation. Results relate to Digexin™, the active ingredient, not to ILURA Digest + Balance as a finished product. Digexin clinical study, NXT USA. Individual results vary.